Form 10 Explorer
10-K
Annual Report
BIO KEY INTERNATIONAL INC

BKYI

NASDAQ

CIK: 1019034

File #: 1-13463

Period End: Dec 31, 2025

Fiscal Year: 2025

View on EDGAR
Balance Sheet
40 line items · 2 periods
XBRL
ItemDec 31, 2025Dec 31, 2024
ASSETS
Cash and cash equivalents
2,694,663437,604
Accounts receivable, net
1,220,822718,229
Due from factor
074,170
Inventory, net of reserve
370,879378,307
Prepaid expenses and other
251,323278,648
Total current assets
4,537,6871,886,958
Equipment and leasehold improvements, net
67,751140,198
Capitalized contract costs, net
311,591409,426
Deposits and other assets
7,9767,976
Operating lease right-of-use assets
47,95373,372
Investment
2,500,0005,000,000
Intangible assets, net
830,3571,097,630
Total non-current assets
3,765,6286,728,602
TOTAL ASSETS
8,303,3158,615,560
LIABILITIES
Accounts payable
507,357818,186
Accrued liabilities
1,333,9301,278,732
Senior Secured Promissory Note
604,1021,525,977
Government Loan
50,530132,731
Deferred revenue – current
572,513773,267
Operating lease liabilities, current portion
27,72824,642
Total current liabilities
3,096,1604,553,535
Deferred revenue, net of current portion
62,584196,237
Deferred tax liability
16,5000
Government loan – BBVA Bank, net of current portion
044,762
Operating lease liabilities, net of current portion
21,26648,994
Total non-current liabilities
100,350289,993
TOTAL LIABILITIES
3,196,5104,843,528
STOCKHOLDERS’ EQUITY
Common stock — authorized, 170,000,000 shares; issued and outstanding; 1,085,360 and 371,696 of $.0001 par value at December 31, 2025 and December 31, 2024, respectively
10937
Additional paid-in capital
141,497,741133,030,607
Accumulated other comprehensive loss
74,80349,290
Accumulated deficit
(136,465,848)(129,307,902)
TOTAL STOCKHOLDERS’ EQUITY
5,106,8053,772,032
Common Stock
10937
Additional Paid-in Capital
141,497,741133,030,607
AOCI Attributable to Parent
74,80349,290
Retained Earnings
(136,465,848)(129,307,902)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
8,303,3158,615,560